diazooxonorleucine has been researched along with Medulloblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Eberhart, CG; Maxwell, MJ; Pham, K; Raabe, EH; Rais, R; Slusher, BS; Sweeney, H | 1 |
| Bigner, DD; Campbell, GL; Dranoff, G; Elion, GB; Friedman, HS | 1 |
2 other study(ies) available for diazooxonorleucine and Medulloblastoma
| Article | Year |
|---|---|
Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
Topics: Animals; Apoptosis; Caproates; Cell Line, Tumor; Cerebellar Neoplasms; Diazooxonorleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Glutamine; Humans; Medulloblastoma; Mice; Mice, Nude | 2021 |
Influence of glutamine on the growth of human glioma and medulloblastoma in culture.
Topics: 2-Aminoadipic Acid; Cells, Cultured; Diazooxonorleucine; Dose-Response Relationship, Drug; Glioma; Glutamate-Ammonia Ligase; Glutamine; Humans; Hydroxylysine; Medulloblastoma | 1985 |